Please note

Due to the recent spike in Covid-19 cases, we are no longer able to entertain walk-in visits to our headquarters or any of our facilities.

OMZ powder for injection

Ferron Par Pharmaceuticals

Ingredients in every vial

Omeprazole 40 mg

Each package contains

1 vial of 40 mg

Dosage form

Powder for injection

Dosage formPowder for injection

Flavour

None

W.H.O. classification

A02A
A02A

A.T.C. Level 1

Anatomical Main group

A - Alimentary tract and metabolism
A02A

A.T.C. Level 2

Therapeutic subgroup

A02 - Drugs for Acid Related Disorders
A02A

A.T.C. Level 3

Pharmacological subgroup

A02A - Antacids

Available in

Indonesia

Warnings

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

CAUTIONThis item may not be safe for use while operating heavy machinery. Use with caution and after consultation with your doctor.

Pregnancy

CAUTIONThis item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.

Lactation

CAUTIONThis item may not be safe for use during lactation. Use with caution and after consultation with your doctor.

Indication

Alternative therapy for the following conditions which cannot be treated effectively with oral medication:
Duodenal ulcer
Gastric ulcer
Reflux Esophagitis
Zollinger-Ellison syndrome

Dosage

18 YEARS OLD AND ABOVE
Omeprazole intravenous should only be used where oral medication is inappropriate, e.g. in severely ill patients. Dose 40 mg once daily.

For the treatment of Zollinger-Ellison syndrome, dosage must be adjusted according to the individual response.

Dilute OMZ® injection with 10 ml WFI, do not use another solvent. Inject over a period of not less than 2.5 minutes. Inject at a rate no greater than 4 ml/min.

UP TO 18 YEARS
There is no experience with omeprazole injection in children.

Dilute OMZ® injection with 10 ml WFI, do not use another solvent. Inject over a period of not less than 2.5 minutes. Inject at a rate no greater than 4 ml/min.

PATIENTS WITH SEVERE RENAL IMPAIRMENT
No dosage adjustment of OMZ® injection is necessary.

PATIENTS WITH SEVERE HEPATIC IMPAIRMENT
No dosage adjustment of OMZ® injection is necessary.

ELDERLY PATIENTS
No dosage adjustment of OMZ® injection is necessary.